Passa al contenuto
Merck

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.

Nature communications (2018-07-22)
Matija Snuderl, Kasthuri Kannan, Elke Pfaff, Shiyang Wang, James M Stafford, Jonathan Serrano, Adriana Heguy, Karina Ray, Arline Faustin, Olga Aminova, Igor Dolgalev, Stacie L Stapleton, David Zagzag, Luis Chiriboga, Sharon L Gardner, Jeffrey H Wisoff, John G Golfinos, David Capper, Volker Hovestadt, Marc K Rosenblum, Dimitris G Placantonakis, Sarah E LeBoeuf, Thales Y Papagiannakopoulos, Lukas Chavez, Sama Ahsan, Charles G Eberhart, Stefan M Pfister, David T W Jones, Matthias A Karajannis
ABSTRACT

Pineoblastoma is a rare and highly aggressive brain cancer of childhood, histologically belonging to the spectrum of primitive neuroectodermal tumors. Patients with germline mutations in DICER1, a ribonuclease involved in microRNA processing, have increased risk of pineoblastoma, but genetic drivers of sporadic pineoblastoma remain unknown. Here, we analyzed pediatric and adult pineoblastoma samples (n = 23) using a combination of genome-wide DNA methylation profiling and whole-exome sequencing or whole-genome sequencing. Pediatric and adult pineoblastomas showed distinct methylation profiles, the latter clustering with lower-grade pineal tumors and normal pineal gland. Recurrent variants were found in genes involved in PKA- and NF-κB signaling, as well as in chromatin remodeling genes. We identified recurrent homozygous deletions of DROSHA, acting upstream of DICER1 in microRNA processing, and a novel microduplication involving chromosomal region 1q21 containing PDE4DIP (myomegalin), comprising the ancient DUF1220 protein domain. Expresion of PDE4DIP and DUF1220 proteins was present exclusively in pineoblastoma with PDE4DIP gain.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Anticorpo anti-Cas9, clone 7A9, clone 7A9, from mouse